Mayo Clinic is a leader in lymphoma research. The Hematologic Malignancies Program conducts research related to lymphoma and other blood and bone marrow cancers.

The National Cancer Institute has designated Mayo Clinic a comprehensive cancer center and helps fund Mayo Clinic's lymphoma research through a Specialized Program of Research Excellence (SPORE) grant. Mayo applies that research to developing more effective and less toxic treatments for all forms of lymphoma. Mayo Clinic conducts many clinical trials to test new therapies for the disease.

Cancer research is conducted in coordination with the Mayo Clinic Cancer Center. The Mayo Clinic Cancer Center receives funding from the National Cancer Institute and is designated as a comprehensive cancer center — recognition for an institution's scientific excellence and multidisciplinary resources focused on cancer prevention, diagnosis and treatment.


See a list of publications by Mayo Clinic authors on lymphoma on PubMed, a service of the National Library of Medicine.

June 01, 2017
  1. AskMayoExpert. Non-Hodgkin lymphoma. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2016.
  2. The lymphoma guide: Information for patients and caregivers. Leukemia & Lymphoma Society. Accessed Feb. 15, 2017.
  3. Adult Hodgkin lymphoma treatment (PDQ). National Cancer Institute.
  4. Adult non-Hodgkin lymphoma treatment (PDQ). National Cancer Institute. Accessed Feb. 23, 2017.
  5. Riggin EA. Allscripts EPSi. Mayo Clinic, Rochester, Minn. Jan. 26, 2017.
  6. Lymphoma SPOREs. National Cancer Institute. Accessed Feb. 23, 2017.